ERIS Lifescience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,399.75
33 (2.41%)
BSENSE

Jun 12, 12:56 PM

BSE+NSE Vol: 32.68 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryERIS Lifescience VS Pharmaceuticals & Biotechnology
 
1D
2.41%
0.92%
1W
2.84%
0.36%
1M
3.15%
-0.07%
YTD
-6.92%
-12.57%
1Y
-21.81%
-8.79%
3Y
112.15%
18.79%
5Y
98.39%
41.99%
10Y
%
179.74%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.53%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.61%
0.55%
4.16%
6 Months
-10.9%
0.45%
-10.45%
1 Year
-21.81%
0.40%
-21.41%
2 Years
37.95%
1.40%
39.35%
3 Years
112.15%
2.15%
114.3%
4 Years
112.65%
3.43%
116.08%
5 Years
98.39%
3.76%
102.15%

Latest dividend: 7.21 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
5.28%
2
Quartile
quartile-2
Dec-Mar
-13.67%
4
Quartile
quartile-4
Sep-Dec
-5.33%
4
Quartile
quartile-4
YTD
-23.66%
2
Quartile
quartile-2
2025
9.85%
3
Quartile
quartile-3
2024
50.33%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
5.28%
2
Quartile
quartile-2
Dec-Mar
-13.67%
3
Quartile
quartile-3
Sep-Dec
-5.33%
3
Quartile
quartile-3
YTD
-23.66%
1
Quartile
quartile-1
2025
9.85%
2
Quartile
quartile-2
2024
50.33%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
5.28%
2
Quartile
quartile-2
Dec-Mar
-13.67%
3
Quartile
quartile-3
Sep-Dec
-5.33%
3
Quartile
quartile-3
YTD
-23.66%
1
Quartile
quartile-1
2025
9.85%
2
Quartile
quartile-2
2024
50.33%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available